WallStreetZenWallStreetZen

NASDAQ: TCRT
Alaunos Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TCRT past revenue growth

How has TCRT's revenue growth performed historically?
Company
-99.83%
Industry
148.4%
Market
16.96%
TCRT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TCRT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TCRT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TCRT earnings and revenue history

Current Revenue
$5.0k
Current Earnings
-$35.1M
Current Profit Margin
-702,800%

TCRT Return on Equity

Current Company
-197%
Current Industry
-63.5%
Current Market
188%
TCRT's Return on Equity (-197%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TCRT announces earnings.

TCRT Return on Assets

Current Company
-134.8%
Current Industry
2.9%
TCRT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TCRT Return on Capital Employed

Current Company
-526.7%
Current Industry
19.5%
TCRT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TCRT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TCRT$5.00k-$30.62M-$35.14M-49.08%N/A
AKTX$0.00-$10.00M-$10.01MN/AN/A
BIOR$4.00k-$113.84M-$124.12M-87.44%N/A
PHGE$0.00-$22.87M-$26.17MN/AN/A
PMCB$0.00-$1.14M-$11.51MN/AN/A
View Top Biotech Stocks

TCRT earnings dates

Next earnings date
May 8, 2024

Alaunos Therapeutics Earnings & Revenue FAQ

What were TCRT's earnings last quarter?

On Invalid Date, Alaunos Therapeutics (NASDAQ: TCRT) reported Q4 2023 earnings per share (EPS) of -$0.55, up 16.67% year over year. Total Alaunos Therapeutics earnings for the quarter were -$7.84 million. In the same quarter last year, Alaunos Therapeutics's earnings per share (EPS) was -$0.66.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.

What was TCRT's earnings growth in the past year?

As of Q2 2024, Alaunos Therapeutics's earnings has grown year over year. Alaunos Therapeutics's earnings in the past year totalled -$35.14 million.

What is TCRT's earnings date?

Alaunos Therapeutics's earnings date is Invalid Date. Add TCRT to your watchlist to be reminded of TCRT's next earnings announcement.

What was TCRT's revenue last quarter?

On Invalid Date, Alaunos Therapeutics (NASDAQ: TCRT) reported Q4 2023 revenue of $1.00 thousand up 90.91% year over year. In the same quarter last year, Alaunos Therapeutics's revenue was $11.00 thousand.

What was TCRT's revenue growth in the past year?

As of Q2 2024, Alaunos Therapeutics's revenue has grown -99.83% year over year. This is 248.23 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Alaunos Therapeutics's revenue in the past year totalled $5.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.